Premium
Determining the best method for first‐line assessment of neonatal blood glucose levels
Author(s) -
Thomas Cl,
Critchley L,
Davies Mw
Publication year - 2000
Publication title -
journal of paediatrics and child health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.631
H-Index - 76
eISSN - 1440-1754
pISSN - 1034-4810
DOI - 10.1046/j.1440-1754.2000.00510.x
Subject(s) - glucose meter , medicine , glucose oxidase , roche diagnostics , blood glucose monitoring , analyser , endocrinology , chromatography , diabetes mellitus , biochemistry , biology , biosensor , chemistry
Objective : To evaluate and compare the accuracy and performance of two electrochemical glucose meters. To determine the user acceptability of these glucose meters and the ABL 620 Blood Gas Analyser (Radiometer, Copenhagen, Denmark) with an electrochemical glucose oxidase electrode for use in a Level 2 special care baby unit. Methodology : A total of 108 blood samples were collected from 47 babies at risk for hypoglycaemia. The blood glucose level was measured with two glucose meters, the Advantage Glucose Meter (Roche Diagnostics, Castle Hill, Australia) and the Precision‐G Blood Glucose Testing System (Medisense, Melbourne, Australia), and the true blood glucose (TBG) measured with the ABL 620 blood gas analyser. Results from the glucose meters were compared with the TBG (as a percentage of the TBG). Results : The mean (SD) percentage difference between the Advantage Glucose Meter and TBG was 4.5% (12.5), and Precision‐G Glucose Meter and TBG was 15.4% (12.4). The sample haematocrit did not significantly influence the glucose meter/TBG differences. There was an overall preference by the nursing staff for the Advantage Glucose Meter. Conclusions : The Advantage Glucose Meter was significantly more accurate than the Precision‐G with similar precision. It was the preferred method of screening for neonatal hypoglycaemia.